BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38936838)

  • 1. Antifungal efficacy of natural antiseptic products against Candida auris.
    Wu WG; Luk KS; Hung MF; Tsang WY; Lee KP; Lam BH; Cheng KL; Cheung WS; Tang HL; To WK
    Med Mycol; 2024 Jun; ():. PubMed ID: 38936838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting the Activity of Chlorhexidine for Decolonization of
    Johnson CJ; Eix EF; Lam BC; Wartman KM; Meudt JJ; Shanmuganayagam D; Nett JE
    J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682225
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of octenidine- and chlorhexidine-based wash-mitts against Candida albicans and Candida auris - a comparative study.
    Gugsch F; Tan CK; Oh DY; Paßvogel L; Steinhauer K
    J Hosp Infect; 2024 Jan; 143():91-96. PubMed ID: 37949371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the yeasticidal efficacy of povidone-iodine-based commercial antiseptic solutions against Candida auris.
    Chesnay A; Bailly É; Desoubeaux G
    J Mycol Med; 2021 Dec; 31(4):101173. PubMed ID: 34271481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of pathogenicity for the emerging fungus Candida auris.
    Horton MV; Holt AM; Nett JE
    PLoS Pathog; 2023 Dec; 19(12):e1011843. PubMed ID: 38127686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeasticidal activity of chemical disinfectants and antiseptics against Candida auris.
    Moore G; Schelenz S; Borman AM; Johnson EM; Brown CS
    J Hosp Infect; 2017 Dec; 97(4):371-375. PubMed ID: 28865738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris.
    Tran HNH; Graham L; Adukwu EC
    Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative efficacy of antiseptics against Candida auris biofilms.
    Kean R; McKloud E; Townsend EM; Sherry L; Delaney C; Jones BL; Williams C; Ramage G
    Int J Antimicrob Agents; 2018 Nov; 52(5):673-677. PubMed ID: 29775686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
    Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
    Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ku TSN; Walraven CJ; Lee SA
    Front Microbiol; 2018; 9():726. PubMed ID: 29706945
    [No Abstract]   [Full Text] [Related]  

  • 11. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
    Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
    Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad susceptibility of
    Lohse MB; Laurie MT; Levan S; Ziv N; Ennis CL; Nobile CJ; DeRisi J; Johnson AD
    mBio; 2023 Aug; 14(4):e0137623. PubMed ID: 37493629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activity of Caryocar brasiliense camb. Alone or along with antifungal agents against multidrug-resistant Candida auris.
    Retore YI; Lucini F; Rial RC; Cardoso CAL; Souza PFN; Simionatto S; Rossato L
    J Ethnopharmacol; 2024 Aug; 330():118240. PubMed ID: 38677574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the
    Li J; Coste AT; Bachmann D; Sanglard D; Lamoth F
    Microbiol Spectr; 2021 Dec; 9(3):e0139521. PubMed ID: 34730380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withania somnifera seed oil exhibits antibiofilm properties against drug-resistant Candida auris clinical isolate through modulation in cell permeability.
    Balkrishna A; Kharayat B; Rastogi S; Kabdwal M; Haldar S; Varshney A
    J Appl Microbiol; 2023 Jun; 134(6):. PubMed ID: 37096387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal Activity of a Medical-Grade Honey Formulation against
    de Groot T; Janssen T; Faro D; Cremers NAJ; Chowdhary A; Meis JF
    J Fungi (Basel); 2021 Jan; 7(1):. PubMed ID: 33450974
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposomal formulation of a new antifungal hybrid compound provides protection against
    Jaromin A; Zarnowski R; Markowski A; Zagórska A; Johnson CJ; Etezadi H; Kihara S; Mota-Santiago P; Nett JE; Boyd BJ; Andes DR
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0095523. PubMed ID: 38092678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating Dual-Species
    Gülmez D; Brown JL; Butcher MC; Delaney C; Kean R; Ramage G; Short B
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884184
    [No Abstract]   [Full Text] [Related]  

  • 19. Host defense mechanisms against
    Pechacek J; Lionakis MS
    Expert Rev Anti Infect Ther; 2023; 21(10):1087-1096. PubMed ID: 37753840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy of disinfectants utilised for skin decolonisation and environmental decontamination during a hospital outbreak with Candida auris.
    Abdolrasouli A; Armstrong-James D; Ryan L; Schelenz S
    Mycoses; 2017 Nov; 60(11):758-763. PubMed ID: 28872735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.